{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T13:51:57Z","timestamp":1760622717047,"version":"3.37.0"},"reference-count":31,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2008,12,16]],"date-time":"2008-12-16T00:00:00Z","timestamp":1229385600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Respirology"],"published-print":{"date-parts":[[2009,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p><jats:bold>Background and objective:\u2003<\/jats:bold>The effects of tiotropium, a long\u2010acting anticholinergic drug, were compared with those of the combination of salmeterol, a long\u2010acting \u03b2<jats:sub>2<\/jats:sub>\u2010agonist, and fluticasone, an inhaled corticosteroid, in patients with COPD.<\/jats:p><jats:p><jats:bold>Methods:\u2003<\/jats:bold>A 4\u2010month, randomized, open cross\u2010over study of tiotropium, 18\u2003\u00b5g once daily, versus salmeterol, 50\u2003\u00b5g, plus fluticasone, 200\u2003\u00b5g, twice daily, was conducted in patients with COPD. Efficacy was assessed by spirometry and responses to the St George's Respiratory Questionnaire (SGRQ). After 4 months, patients were asked to select their subsequent therapy and indicate the reasons for their selection.<\/jats:p><jats:p><jats:bold>Results:\u2003<\/jats:bold>A total of 78 patients completed the study. There were no significant differences in the improvements in FEV<jats:sub>1<\/jats:sub>or SGRQ scores between the therapies. Similar numbers of patients selected tiotropium (42.3%) and salmeterol plus fluticasone (57.7%). However, those who preferred one of the therapies demonstrated greater improvements in SGRQ scores with that therapy. One subgroup of patients (30.8%) showed greater improvements in dyspnoea and FEV<jats:sub>1<\/jats:sub>in response to tiotropium, and the other subgroup of patients (35.9%) showed greater improvements in dyspnoea and FEV<jats:sub>1<\/jats:sub>in response to salmeterol plus fluticasone. Some patients (14.1%) selected salmeterol plus fluticasone because of positive effects on sputum expectoration.<\/jats:p><jats:p><jats:bold>Conclusions:\u2003<\/jats:bold>The study was unblinded and the results need to be interpreted with caution. However, tiotropium and salmeterol plus fluticasone had similar overall effects on pulmonary function and SGRQ scores in patients with COPD. Responses to the two therapies were heterogeneous, and the patients who showed greater improvements in FEV<jats:sub>1<\/jats:sub>or SGRQ scores with one of the therapies preferred it for their subsequent treatment.<\/jats:p>","DOI":"10.1111\/j.1440-1843.2008.01452.x","type":"journal-article","created":{"date-parts":[[2008,12,17]],"date-time":"2008-12-17T16:36:55Z","timestamp":1229531815000},"page":"239-244","source":"Crossref","is-referenced-by-count":14,"title":["Changes in lung function and health status in patients with COPD treated with tiotropium or salmeterol plus fluticasone"],"prefix":"10.1111","volume":"14","author":[{"given":"Kazuyoshi","family":"KURASHIMA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichirou","family":"HARA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouichirou","family":"YONEDA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsu","family":"KANAUCHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naho","family":"KAGIYAMA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daido","family":"TOKUNAGA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noboru","family":"TAKAYANAGI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikio","family":"UBUKATA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"SUGITA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,2,25]]},"reference":[{"key":"e_1_2_6_2_2","unstructured":"Global Initiative for Chronic Obstructive Lung Disease.Global strategy for the diagnosis management and prevention of chronic obstructive pulmonary disease. National Heart Lung and Blood Institute\/World Health Organization 2003. [Accessed 18 April 2004.] Available from URL:http:\/\/www.goldcopd.com"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.04.00014304"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198408163110701"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(98)00588-8"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.122.1.47"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2006.063271"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.58.5.399"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.2112055"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa063070"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200707-973OC"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.123.5.1441"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2006.10.001"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.02.00063702"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12459-2"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.320.7245.1297"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032158"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00023907"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.2105025"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200508-1321OC"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2006.071068"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0954-6111(99)90038-0"},{"key":"e_1_2_6_23_2","unstructured":"Global Initiative for Chronic Obstructive Lung Disease.Global strategy for the diagnosis management and prevention of chronic obstructive pulmonary disease. National Heart Lung and Blood Institute\/World Health Organization 2006. [Accessed 11 July 2007.] Available from URL:http:\/\/www.goldcopd.com"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2003.1558"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.130.6.1695"},{"key":"e_1_2_6_26_2","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0026-895X(25)10204-6","article-title":"Characterization of [3H]Ba 679 BR, a slowly dissociating muscarinic antagonist, in human lung: radioligand binding and autoradiographic mapping","volume":"45","author":"Haddad EB","year":"1994","journal-title":"Mol. Pharmacol."},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.prrv.2006.04.198"},{"key":"e_1_2_6_28_2","first-page":"L223","article-title":"Muscarinic receptor subtypes in feline tracheal submucosal gland secretion","volume":"262","author":"Ishihara H","year":"1992","journal-title":"Am. J. Physiol."},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-197601000-00020"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.125.5.1726"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.164.2.2008094"},{"key":"e_1_2_6_32_2","first-page":"1159","article-title":"Inhaled adrenergics and anticholinergics in obstructive lung disease: do they enhance mucociliary clearance?","volume":"52","author":"Restrepo RD.","year":"2007","journal-title":"Respir. Care"}],"container-title":["Respirology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1843.2008.01452.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1843.2008.01452.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T07:05:45Z","timestamp":1738825545000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1843.2008.01452.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,25]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["10.1111\/j.1440-1843.2008.01452.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1843.2008.01452.x","archive":["Portico"],"relation":{},"ISSN":["1323-7799","1440-1843"],"issn-type":[{"type":"print","value":"1323-7799"},{"type":"electronic","value":"1440-1843"}],"subject":[],"published":{"date-parts":[[2009,2,25]]}}}